“`html
Zoetis Inc. (ZTS) closed at $168.82, reflecting a 1.5% increase from the previous day on [date]. The stock outperformed the S&P 500, which rose by 0.38%. Over the past month, Zoetis shares have appreciated by 7.37%, compared to a 6.6% gain for the S&P 500 and 4.64% for the Medical sector.
The company is expected to report earnings of $1.61 per share for the upcoming quarter, marking a 3.21% increase year-over-year, with anticipated revenue of $2.4 billion, a growth of 1.67%. Full-year estimates predict earnings of $6.26 per share and revenue of $9.49 billion, which would represent increases of 5.74% and 2.53%, respectively, compared to the previous year.
Zoetis currently holds a Zacks Rank of #3 (Hold) with a Forward P/E ratio of 26.59, higher than the industry average of 16.43. The Medical – Drugs industry ranks in the top 29% of over 250 industries, indicating a strong position within the sector.
“`
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
